Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million 2023-06-16 14:20
NABR Files Petition Challenging the Listing of Long-Tailed Macaque by the IUCN 2023-06-16 10:30
Everest Medicines Appoints Dr. Mike Berry as Chief Technology Officer 2023-06-16 07:45
Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall 2023-06-16 06:05
Qiming Venture Partners fosters life science, medical and healthcare talent development First healthcare catalyst program starts recruiting in Hong Kong universities 2023-06-15 22:58
HistoIndex SHG/TPE imaging and AI-based technology reveals dose-dependent effectiveness of Tropifexor for NASH patients in Nature Medicine 2023-06-15 20:00
TANDEM study shows potential of HistoIndex SHG/TPE imaging and AI-based technology in evaluating the effects of combination therapy for NASH 2023-06-15 20:00
EW Group Signs with China's Largest Healthcare, Sinopharm 2023-06-15 10:24
NCCN Debuts Roadmap for Improving Thyroid Cancer Care in Low- and Middle-Income Countries on World Stage 2023-06-14 20:06
MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China 2023-06-14 20:00
Sirnaomics to Present Latest Developments on GalAhead™ Therapeutic Platform at Upcoming Industry Conferences 2023-06-14 00:42
Metabolon Announces Three Oral Presentations and Two Poster Presentations at the 2023 Metabolomics Society Annual Conference 2023-06-13 20:57
GORE INITIATES STUDY TO COMPARE THE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS TO BARE METAL STENTS 2023-06-13 20:00
HKSH Medical Group and UCLA Health signed a Development Agreement 2023-06-12 19:25
The 20th CACLP & 3rd CISCE Closed with Record-breaking Numbers in Nanchang 2023-06-12 18:45
Taipei Entrepreneurs Hub Focuses on the Greater Health Industries, Taipei City Government Facilitates Global Talents Matchmaking 2023-06-12 16:12
Innovent Announces Phase 1 Clinical Data of IBI322 (CD47/PD-L1 Bispecific Antibody) in the Treatment of Anti-PD-(L)1-resistant Classic Hodgkin Lymphoma Patients at the EHA 2023 Annual Meeting 2023-06-12 08:00
DxVx, won the governmental project to develop diagnostic sensor kit for adult diseases 2023-06-09 21:00
Treating COVID with Metformin Reduces Long COVID Rates 2023-06-09 21:00
Anti-Aging and Reproductive Medical Giants Gathered in Hong Kong Dragon's Medical Led Chinese Medical Development 2023-06-09 13:00
1 102 103 104 105 106 531